NYSE: CNMDConmed Corp Stock Ownership - Who owns Conmed?
Insider buying vs selling
Have Conmed Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Charles Farkas | Director | 2025-05-29 | 1,000 | $55.70 | $55.70kBuy |
| Charles Farkas | Director | 2025-05-29 | 966 | $57.69 | $55.73kSell |
| John L. Workman | Director | 2025-05-20 | 479 | $59.84 | $28.66kBuy |
| Charles Farkas | Director | 2025-05-05 | 4,000 | $56.94 | $227.77kSell |
| Todd W. Garner | Executive Vice President CFO | 2025-03-31 | 371 | $57.37 | $21.28kBuy |
| Peter K. Shagory | EVP STRAT CORP DEVT | 2025-03-14 | 4,500 | $55.42 | $249.39kBuy |
| Peter K. Shagory | EVP STRAT CORP DEVT | 2025-03-14 | 4,316 | $58.83 | $253.91kSell |
| Brent Lalomia | Vice President QA and RA | 2025-03-07 | 26 | $62.74 | $1.63kSell |
| Brent Lalomia | Executive VP RA QA | 2024-12-31 | 22 | $68.44 | $1.51kBuy |
| Richard Glaze | Chief Information Officer | 2024-11-20 | 118 | $70.69 | $8.34kSell |
CNMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNMD insiders and whales buy or sell their stock.
CNMD Shareholders
What type of owners hold Conmed Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.91% | 4,923,198 | $260.49M | Institution |
| Vanguard Group Inc | 11.33% | 3,505,575 | $185.48M | Institution |
| Earnest Partners LLC | 9.05% | 2,799,699 | $148.13M | Institution |
| Capital Research Global Investors | 5.41% | 1,673,404 | $88.54M | Institution |
| Bank Of America Corp | 4.51% | 1,393,946 | $73.75M | Institution |
| State Street Corp | 4.21% | 1,301,539 | $68.86M | Institution |
| Westwood Holdings Group Inc | 4.00% | 1,237,735 | $65.49M | Institution |
| Fuller Thaler Asset Management Inc | 3.79% | 1,174,032 | $62.12M | Institution |
| Champlain Investment Partners LLC | 3.37% | 1,042,365 | $55.15M | Institution |
| Silvercrest Asset Management Group LLC | 3.35% | 1,035,604 | $54.79M | Institution |
CNMD vs Medical Device Stocks
Conmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.